Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center.

Sonia Vallet; Sascha Pahernik; Thomas Höfner; Georgi Tosev; Boris Hadaschik; Stefan Duensing; Oliver Sedlaczek; Markus Hohenfellner; Dirk Jäger; Carsten Grüllich

doi:10.1016/j.clgc.2014.12.012

Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center.

Sonia Vallet, Sascha Pahernik (Co-Autor/-in), Thomas Höfner, Georgi Tosev, Boris Hadaschik, Stefan Duensing, Oliver Sedlaczek, Markus Hohenfellner, Dirk Jäger, Carsten Grüllich

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

17 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	e14-e52
Fachzeitschrift	CLINICAL GENITOURINARY CANCER
Jahrgang	13
Ausgabenummer	3
DOIs	https://doi.org/10.1016/j.clgc.2014.12.012
Publikationsstatus	Veröffentlicht - 2015

Zugriff auf Dokument

10.1016/j.clgc.2014.12.012

Dieses zitieren

Vallet, S., Pahernik, S., Höfner, T., Tosev, G., Hadaschik, B., Duensing, S., Sedlaczek, O., Hohenfellner, M., Jäger, D., & Grüllich, C. (2015). Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center. CLINICAL GENITOURINARY CANCER, 13(3), e14-e52. https://doi.org/10.1016/j.clgc.2014.12.012

@article{56219b03533c40be87f6d3cd77ee343d,

title = "Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center.",

keywords = "RENAL-CELL CARCINOMA, PHASE-III TRIAL, SEQUENTIAL THERAPY, INTERFERON-ALPHA, DOUBLE-BLIND, 3 LINES, SURVIVAL, SUNITINIB, SORAFENIB, PROGRESSION",

author = "Sonia Vallet and Sascha Pahernik and Thomas H{\"o}fner and Georgi Tosev and Boris Hadaschik and Stefan Duensing and Oliver Sedlaczek and Markus Hohenfellner and Dirk J{\"a}ger and Carsten Gr{\"u}llich",

year = "2015",

doi = "10.1016/j.clgc.2014.12.012",

language = "English",

volume = "13",

pages = "e14--e52",

journal = "CLINICAL GENITOURINARY CANCER",

issn = "1558-7673",

number = "3",

}

Vallet, S, Pahernik, S, Höfner, T, Tosev, G, Hadaschik, B, Duensing, S, Sedlaczek, O, Hohenfellner, M, Jäger, D & Grüllich, C 2015, 'Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center.', CLINICAL GENITOURINARY CANCER, Jg. 13, Nr. 3, S. e14-e52. https://doi.org/10.1016/j.clgc.2014.12.012

TY - JOUR

T1 - Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center.

AU - Vallet, Sonia

AU - Pahernik, Sascha

AU - Höfner, Thomas

AU - Tosev, Georgi

AU - Hadaschik, Boris

AU - Duensing, Stefan

AU - Sedlaczek, Oliver

AU - Hohenfellner, Markus

AU - Jäger, Dirk

AU - Grüllich, Carsten

PY - 2015

Y1 - 2015

KW - RENAL-CELL CARCINOMA

KW - PHASE-III TRIAL

KW - SEQUENTIAL THERAPY

KW - INTERFERON-ALPHA

KW - DOUBLE-BLIND

KW - 3 LINES

KW - SURVIVAL

KW - SUNITINIB

KW - SORAFENIB

KW - PROGRESSION

U2 - 10.1016/j.clgc.2014.12.012

DO - 10.1016/j.clgc.2014.12.012

M3 - Original Article

C2 - 25596830

SN - 1558-7673

VL - 13

SP - e14-e52

JO - CLINICAL GENITOURINARY CANCER

JF - CLINICAL GENITOURINARY CANCER

IS - 3

ER -